Join the 'Atomoxetine' group to help and get support from people like you. How it works
Atomoxetine Blog
| Tweet |
Another Drug 'Take-Back Day' Scheduled for Saturday
Posted 26 Apr 2012 by Drugs.com
THURSDAY, April 26 – The fourth National Prescription Drug Take-Back Day is scheduled for Saturday from 10 a.m. to 2 p.m., the U.S. Drug Enforcement Administration says. The event gives Americans an opportunity to safely dispose of unwanted and unused prescription drugs. At the third Take-Back Day last October, participants turned in more than 377,000 pounds (188.5 tons) of unwanted or expired medications at more than 5,300 sites located in all 50 states. In total, the three Take-Back Days have taken in nearly 1 million pounds of prescription drugs during the past 13 months. "The amount of prescription drugs turned in by the American public during the past three Take-Back Day events speaks volumes about the need to develop a convenient way to rid homes of unwanted or expired prescription drugs," DEA administrator Michele Leonhart said in an agency news release. "The DEA remains hard at ... Read more
Related support groups: Suboxone, Xanax, Methadone, Oxycodone, Percocet, OxyContin, Hydrocodone, Vicodin, Adderall, Morphine, Norco, Fentanyl, Klonopin, Lortab, Subutex
ADHD Diagnosis Rates Rose Sharply in Past Decade
Posted 23 Mar 2012 by Drugs.com
FRIDAY, March 23 – In the past decade, the number of children receiving a diagnosis of attention-deficit hyperactivity disorder (ADHD) has risen by 66 percent, new research indicates. In 2000, just 6.2 million physician office visits resulted in a diagnosis of ADHD. By 2010, that number had jumped to 10.4 million office visits. "This study is really like a 10,000 foot aerial view of this issue," said study author Dr. Craig Garfield, an assistant professor of pediatrics and medical social sciences at Northwestern University in Chicago. "We looked at the trends in visits to doctors for ADHD over the last decade, and we were interested in overlaying some of the FDA's public health advisories and the introduction of new medications to see the effect on those trends." The findings are published in the March/April issue of Academic Pediatrics. ADHD is now a common condition in children and ... Read more
Related support groups: Attention Deficit Hyperactivity Disorder (ADHD), Adderall, Adderall XR, Strattera, Amphetamine/Dextroamphetamine, Atomoxetine
ADHD Drugs Don't Raise Risk of Heart Problems: Study
Posted 12 Dec 2011 by Drugs.com
MONDAY, Dec. 12 – Young and middle-aged adults taking drugs for attention deficit-hyperactivity disorder (ADHD) do not seem to face an increased risk for cardiovascular disease, a new study finds. There have been fears that these drugs can cause increases in heart rate and blood pressure, but this large, observational study found no evidence that these effects posed a risk, the researchers said. "The results of our study do not support an increased risk of myocardial infarction, sudden cardiac death or stroke associated with use of ADHD medications in young and middle-aged adults," said lead researcher Laurel Habel, from the division of research at Kaiser Permanente Northern California, in Oakland. "However, as with any study such as ours, there are limitations to the data and we cannot completely rule out a modestly elevated risk." That's because the study relied on data gleaned from ... Read more
Related support groups: Attention Deficit Hyperactivity Disorder (ADHD), Adderall, Concerta, Ritalin, Adderall XR, Strattera, Methylphenidate, Methylin, Daytrana, Metadate CD, Ritalin LA, Methylin ER, Amphetamine/Dextroamphetamine, Atomoxetine, Ritalin-SR
Vanderbilt Study Finds No Heart Risk in ADHD Medications
Posted 2 Nov 2011 by Drugs.com
NASHVILLE, Tenn., Nov 1, 2011 - Attention Deficit Hyperactivity Disorder (ADHD) medications do not increase the risk for heart disease or heart attack in children and young adults, according to a Vanderbilt study of 1.2 million patients taking drugs including Ritalin, Adderall, Concerta and Strattera between 1998 and 2005. The study, published online today by the New England Journal of Medicine (NEJM) and authored by William Cooper, M.D., MPH, a Vanderbilt Professor of Pediatrics and Preventive Medicine, is the largest ever to examine potential risks posed by drugs to treat ADHD. “It should be reassuring that we found no evidence that these drugs increase the risk of serious cardiovascular events on a population basis,” Cooper said. “However, each child is unique, so families and providers need to work together to make informed decisions about the best options for their children. This is ... Read more
Related support groups: Attention Deficit Hyperactivity Disorder (ADHD), Adderall, Concerta, Ritalin, Adderall XR, Strattera, Methylphenidate, Methylin, Daytrana, Metadate CD, Ritalin LA, Methylin ER, Amphetamine/Dextroamphetamine, Atomoxetine, Ritalin-SR
Little Evidence of Heart Risks From ADHD Meds
Posted 1 Nov 2011 by Drugs.com
TUESDAY, Nov. 1 – Medications commonly used to treat attention-deficit/hyperactivity disorder don't appear to raise the risk of heart attacks and other cardiovascular problems in children and young adults, new research shows. And if any increased risk from stimulants such as Ritalin, Adderall and Concerta does exist, the danger in absolute numbers would be extremely low, said Dr. William O. Cooper, lead author of a study published online Nov. 1 in the New England Journal of Medicine. "This is the largest study to date, and I feel this provides reassuring information about risk," said Cooper, a professor of pediatrics and preventive medicine at Vanderbilt University in Nashville, Tenn. Almost 3 million children in the United States take prescription medications for attention-deficit/hyperactivity disorder (ADHD) each year. Children with the neurobehavioral disorder have excessive levels ... Read more
Related support groups: Attention Deficit Hyperactivity Disorder (ADHD), Adderall, Concerta, Ritalin, Adderall XR, Focalin, Strattera, Dextroamphetamine, Focalin XR, Methylphenidate, Dexedrine, Methylin, Daytrana, Ritalin LA, Metadate CD
Prescriptions for Stimulants, Painkillers Soaring Among Youth
Posted 30 Nov 2010 by Drugs.com
TUESDAY, Nov. 30 – The number of prescriptions for controlled medications such as opioids and stimulants has nearly doubled in adolescents and young adults since 1994. The trend, reported in the December issue of Pediatrics, mirrors a similar increase in misuse of these drugs, with adolescents and young adults' illicit use of prescription drugs now outstripping all other illicit drug use except marijuana. The researchers couldn't attribute the increased misuse directly to more prescriptions, but did urge both physicians and patients to be vigilant when considering the use of drugs such as Oxycontin or Ritalin. "Our study did not look at the relationship between prescribing and misuse, but the increased prescribing increases the potential availability [of these drugs]," said study author Dr. Robert Fortuna, an assistant professor of internal medicine and pediatrics at the University of ... Read more
Related support groups: Suboxone, Methadone, Oxycodone, Percocet, OxyContin, Hydrocodone, Vicodin, Adderall, Morphine, Norco, Fentanyl, Lortab, Subutex, Opana, Phentermine
Ask a Question
Further Information
Related Condition Support Groups
Attention Deficit Hyperactivity Disorder (ADHD), Depression, Social Anxiety Disorder, Fibromyalgia